tetano
Editor, Senior Moderator
Biomaterials. 2015 Nov 30;78:74-85. doi: 10.1016/j.biomaterials.2015.11.034. [Epub ahead of print]
[h=1]Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect.[/h] Xiao S[SUP]1[/SUP], Si L[SUP]2[/SUP], Tian Z[SUP]2[/SUP], Jiao P[SUP]2[/SUP], Fan Z[SUP]2[/SUP], Meng K[SUP]2[/SUP], Zhou X[SUP]2[/SUP], Wang H[SUP]2[/SUP], Xu R[SUP]2[/SUP], Han X[SUP]2[/SUP], Fu G[SUP]2[/SUP], Zhang Y[SUP]3[/SUP], Zhang L[SUP]2[/SUP], Zhou D[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Multivalent effect plays an important role in biological processes, particularly in the specific recognition of virus with its host cell during the first step of infection. Here we report the synthesis of multivalent pentacyclic triterpene grafted on cyclodextrin core and potency of against influenza entry activity. Nine star-shaped compounds containing six, seven and eight pentacyclic triterpene pharmacophore on cyclodextrin scaffold were prepared by way of copper-catalyzed azide-alkyl cycloaddition reaction under microwave activation. Some of the multimers exhibited much potent antiviral activity against H1N1 virus (A/WSN/33), even equivalent or superior to oseltamivir. The most active compound 31, a heptavalent oleanolic acid-β-cyclodextrin conjugate, shows an up to 125-fold potency enhancement by its IC[SUB]50[/SUB] value over the corresponding monovalent conjugate and oleanolic acid, disclosing a clear multivalent effect. Further studies show that three compounds 31-33 exhibited broad spectrum inhibitory activity against other two human influenza A/JX/312 (H3N2) and A/HN/1222 (H3N2) viruses with the IC[SUB]50[/SUB] values at 2.47-14.90 μM. Most importantly, we found that compound 31, one of the best representative conjugate, binds tightly to the viral envelope hemagglutinin with a dissociation constant of K[SUB]D[/SUB] = 2.08 μM, disrupting the interaction of hemagglutinin with the sialic acid receptor and thus the attachment of viruses to host cells. Our study might establish a strategy for the design of new pharmaceutical agents based on multivalency so as to block influenza virus entry into host cells.
Copyright ? 2015 Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] Entry inhibitor; Hemagglutinin; Influenza virus; Multivalent effect; Pentacyclic triterpene
PMID: 26686050 [PubMed - as supplied by publisher]
[h=1]Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect.[/h] Xiao S[SUP]1[/SUP], Si L[SUP]2[/SUP], Tian Z[SUP]2[/SUP], Jiao P[SUP]2[/SUP], Fan Z[SUP]2[/SUP], Meng K[SUP]2[/SUP], Zhou X[SUP]2[/SUP], Wang H[SUP]2[/SUP], Xu R[SUP]2[/SUP], Han X[SUP]2[/SUP], Fu G[SUP]2[/SUP], Zhang Y[SUP]3[/SUP], Zhang L[SUP]2[/SUP], Zhou D[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Multivalent effect plays an important role in biological processes, particularly in the specific recognition of virus with its host cell during the first step of infection. Here we report the synthesis of multivalent pentacyclic triterpene grafted on cyclodextrin core and potency of against influenza entry activity. Nine star-shaped compounds containing six, seven and eight pentacyclic triterpene pharmacophore on cyclodextrin scaffold were prepared by way of copper-catalyzed azide-alkyl cycloaddition reaction under microwave activation. Some of the multimers exhibited much potent antiviral activity against H1N1 virus (A/WSN/33), even equivalent or superior to oseltamivir. The most active compound 31, a heptavalent oleanolic acid-β-cyclodextrin conjugate, shows an up to 125-fold potency enhancement by its IC[SUB]50[/SUB] value over the corresponding monovalent conjugate and oleanolic acid, disclosing a clear multivalent effect. Further studies show that three compounds 31-33 exhibited broad spectrum inhibitory activity against other two human influenza A/JX/312 (H3N2) and A/HN/1222 (H3N2) viruses with the IC[SUB]50[/SUB] values at 2.47-14.90 μM. Most importantly, we found that compound 31, one of the best representative conjugate, binds tightly to the viral envelope hemagglutinin with a dissociation constant of K[SUB]D[/SUB] = 2.08 μM, disrupting the interaction of hemagglutinin with the sialic acid receptor and thus the attachment of viruses to host cells. Our study might establish a strategy for the design of new pharmaceutical agents based on multivalency so as to block influenza virus entry into host cells.
Copyright ? 2015 Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] Entry inhibitor; Hemagglutinin; Influenza virus; Multivalent effect; Pentacyclic triterpene
PMID: 26686050 [PubMed - as supplied by publisher]